| Zhanna Mikulik, MD | |
|
480 Medical Center Dr, Columbus, OH 43210-1229 | |
| (614) 293-4837 | |
| (614) 293-5631 |
| Full Name | Zhanna Mikulik |
|---|---|
| Gender | Female |
| Speciality | Rheumatology |
| Experience | 37 Years |
| Location | 480 Medical Center Dr, Columbus, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245245786 | NPI | - | NPPES |
| 2562730 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | 35082940 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ohio State University State Health System | Columbus, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Osu Internal Medicine Llc | 5496651408 | 984 |
News Archive
The role of artificial intelligence, or machine learning, will be pivotal as the industry wrestles with a gargantuan amount of data that could improve - or muddle - health and cost priorities, according to a National Academy of Medicine Special Publication on the use of AI in health care.
Gilead Sciences, Inc. today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for marketing approval of the single-tablet regimen of Truvada® (emtricitabine and tenofovir disoproxil fumarate) and Tibotec Pharmaceuticals' investigational non-nucleoside reverse transcriptase inhibitor TMC278 (rilpivirine hydrochloride) for HIV-1 infection in adults. If approved, this would be the second product that contains a complete HIV treatment regimen in a single once-daily tablet.
The Michigan State Medical Society (MSMS) today applauded the wisdom of the Michigan legislature to enact legislation to make workplaces in our state smoke-free.
Scientists will gather in Addis Ababa, Ethiopia, beginning Monday for a workshop that aims to address climate and health issues, VOA News reports.
Cipher Pharmaceuticals Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Absorica, Cipher's novel, patented brand formulation of the acne medication isotretinoin, for the treatment of severe recalcitrant nodular acne.
› Verified 4 days ago
| Entity Name | Osu Internal Medicine Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740231448 PECOS PAC ID: 5496651408 Enrollment ID: O20031210000658 |
News Archive
The role of artificial intelligence, or machine learning, will be pivotal as the industry wrestles with a gargantuan amount of data that could improve - or muddle - health and cost priorities, according to a National Academy of Medicine Special Publication on the use of AI in health care.
Gilead Sciences, Inc. today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for marketing approval of the single-tablet regimen of Truvada® (emtricitabine and tenofovir disoproxil fumarate) and Tibotec Pharmaceuticals' investigational non-nucleoside reverse transcriptase inhibitor TMC278 (rilpivirine hydrochloride) for HIV-1 infection in adults. If approved, this would be the second product that contains a complete HIV treatment regimen in a single once-daily tablet.
The Michigan State Medical Society (MSMS) today applauded the wisdom of the Michigan legislature to enact legislation to make workplaces in our state smoke-free.
Scientists will gather in Addis Ababa, Ethiopia, beginning Monday for a workshop that aims to address climate and health issues, VOA News reports.
Cipher Pharmaceuticals Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Absorica, Cipher's novel, patented brand formulation of the acne medication isotretinoin, for the treatment of severe recalcitrant nodular acne.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Zhanna Mikulik, MD 700 Ackerman Rd Ste 2120, Columbus, OH 43202-1559 Ph: (614) 293-4837 | Zhanna Mikulik, MD 480 Medical Center Dr, Columbus, OH 43210-1229 Ph: (614) 293-4837 |
News Archive
The role of artificial intelligence, or machine learning, will be pivotal as the industry wrestles with a gargantuan amount of data that could improve - or muddle - health and cost priorities, according to a National Academy of Medicine Special Publication on the use of AI in health care.
Gilead Sciences, Inc. today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for marketing approval of the single-tablet regimen of Truvada® (emtricitabine and tenofovir disoproxil fumarate) and Tibotec Pharmaceuticals' investigational non-nucleoside reverse transcriptase inhibitor TMC278 (rilpivirine hydrochloride) for HIV-1 infection in adults. If approved, this would be the second product that contains a complete HIV treatment regimen in a single once-daily tablet.
The Michigan State Medical Society (MSMS) today applauded the wisdom of the Michigan legislature to enact legislation to make workplaces in our state smoke-free.
Scientists will gather in Addis Ababa, Ethiopia, beginning Monday for a workshop that aims to address climate and health issues, VOA News reports.
Cipher Pharmaceuticals Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Absorica, Cipher's novel, patented brand formulation of the acne medication isotretinoin, for the treatment of severe recalcitrant nodular acne.
› Verified 4 days ago
Sethu M. Madhavan, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 300 W 10th Ave, Columbus, OH 43210 Phone: 614-293-3387 Fax: 614-366-0073 | |
Amrik Singh Khalsa, M.D. Rheumatology Medicare: Medicare Enrolled Practice Location: 700 Childrens Dr, Columbus, OH 43205 Phone: 614-722-2000 Fax: 614-722-4966 | |
Samuel Y. Han, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 410 W 10th Ave, Columbus, OH 43210 Phone: 614-293-6255 Fax: 614-293-1456 | |
Dr. Ruchi Bhatia, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3400 Olentangy River Rd, Columbus, OH 43202 Phone: 614-754-5500 Fax: 614-457-9519 | |
Adam T. Ramey, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 410 W 10th Ave, Columbus, OH 43210 Phone: 614-293-7499 Fax: 614-366-2360 | |
Albert J. Cook, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 460 W 10th Ave, Columbus, OH 43210 Phone: 614-293-2957 Fax: 614-685-6533 | |
Walter G. Hanel Iv, MD, PHD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 460 W 10th Ave, Columbus, OH 43210 Phone: 614-293-3196 Fax: 614-293-4812 |